Research Article

Design and In Silico and In Vitro Evaluations of a Novel Nicotinamide Derivative as a VEGFR-2 Inhibitor

Figure 3

(a) 2D and (b) 3D images of sorafenib inside the VEGFR-2 active site (hydrogen bonds = green dashed lines, electrostatic interactions = orange dashed lines, pi-pi interactions = deep pink dashed lines, and pi-alkyl interactions = light pink dashed lines).
(a)
(b)